Form 8-K - Current report:
SEC Accession No. 0001576280-22-000118
Filing Date
2022-12-15
Accepted
2022-12-15 16:17:59
Documents
14
Period of Report
2022-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20221215.htm   iXBRL 8-K 38279
2 EX-99.1 gh-12152022xexhibit991.htm EX-99.1 24818
6 GRAPHIC guardantlogoa01.gif GRAPHIC 17260
  Complete submission text file 0001576280-22-000118.txt   230900

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20221215.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20221215_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20221215_pre.xml EX-101.PRE 12603
8 EXTRACTED XBRL INSTANCE DOCUMENT gh-20221215_htm.xml XML 11248
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 221465037
SIC: 8071 Services-Medical Laboratories